Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125623761 | 12562376 | 1 | I | 20160511 | 20160705 | 20160715 | 20160715 | EXP | FR-TEVA-675069ISR | TEVA | 70.17 | YR | F | Y | 52.00000 | KG | 20160715 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125623761 | 12562376 | 1 | PS | DOCORUBICINE TEVA | DOXORUBICIN | 1 | R-CHOP PROTOCOL | Y | 63097 | ||||||||||
| 125623761 | 12562376 | 2 | SS | MABTHERA | RITUXIMAB | 1 | R-CHOP PROTOCOL | Y | 0 | ||||||||||
| 125623761 | 12562376 | 3 | SS | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | R-CHOP PROTOCOL | Y | 0 | ||||||||||
| 125623761 | 12562376 | 4 | SS | VINCRISTINE HOSPIRA | VINCRISTINE | 1 | R-CHOP PROTOCOL | Y | 0 | ||||||||||
| 125623761 | 12562376 | 5 | SS | CORTANCYL | PREDNISONE | 1 | R-CHOP PROTOCOL | Y | 0 | ||||||||||
| 125623761 | 12562376 | 6 | C | FORLAX | POLYETHYLENE GLYCOL 4000 | 1 | 2 DOSAGE FORMS DAILY; LONG-STANDING TREATMENT | 0 | 2 | DF | QD | ||||||||
| 125623761 | 12562376 | 7 | C | ALDACTAZINE | ALTHIAZIDESPIRONOLACTONE | 1 | .5 DOSAGE FORMS DAILY; LONG-STANDING TREATMENT | 0 | |||||||||||
| 125623761 | 12562376 | 8 | C | EUPANTOL | PANTOPRAZOLE SODIUM | 1 | 20 MILLIGRAM DAILY; LONG-STANDING TREATMENT | 0 | |||||||||||
| 125623761 | 12562376 | 9 | C | DIFFU K | POTASSIUM CHLORIDE | 1 | LONG-STANDING TREATMENT | 0 | |||||||||||
| 125623761 | 12562376 | 10 | C | GRANOCYTE | LENOGRASTIM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125623761 | 12562376 | 1 | Non-Hodgkin's lymphoma |
| 125623761 | 12562376 | 2 | Non-Hodgkin's lymphoma |
| 125623761 | 12562376 | 3 | Non-Hodgkin's lymphoma |
| 125623761 | 12562376 | 4 | Non-Hodgkin's lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125623761 | 12562376 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125623761 | 12562376 | Bacteraemia | |
| 125623761 | 12562376 | Febrile bone marrow aplasia | |
| 125623761 | 12562376 | Febrile neutropenia | |
| 125623761 | 12562376 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125623761 | 12562376 | 1 | 201512 | 20160502 | 0 | |
| 125623761 | 12562376 | 2 | 201512 | 20160502 | 0 | |
| 125623761 | 12562376 | 3 | 201512 | 20160502 | 0 | |
| 125623761 | 12562376 | 4 | 201512 | 20160502 | 0 | |
| 125623761 | 12562376 | 5 | 201512 | 20160502 | 0 | |
| 125623761 | 12562376 | 10 | 20160504 | 20160513 | 0 |